Cargando…
A diversity outbred F1 mouse model identifies host-intrinsic genetic regulators of response to immune checkpoint inhibitors
Immune checkpoint inhibitors (ICI) have improved outcomes for a variety of malignancies; however, many patients fail to benefit. While tumor-intrinsic mechanisms are likely involved in therapy resistance, it is unclear to what extent host genetic background influences response. To investigate this,...
Autores principales: | Hackett, Justin B., Glassbrook, James E., Muñiz, Maria C., Bross, Madeline, Fielder, Abigail, Dyson, Gregory, Movahhedin, Nasrin, McCasland, Jennifer, McCarthy-Leo, Claire, Gibson, Heather M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037414/ https://www.ncbi.nlm.nih.gov/pubmed/35481286 http://dx.doi.org/10.1080/2162402X.2022.2064958 |
Ejemplares similares
-
Transmission of Food Preference does Not Require Socially Relevant Cues in a Mouse Strain with Low Sociability
por: Zaccaria, Kimberly J., et al.
Publicado: (2010) -
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study
por: Kristensen, Lars Erik, et al.
Publicado: (2022) -
Evaluation of an ImmunoPET Tracer for IL-12 in a Preclinical Model of Inflammatory Immune Responses
por: Viola, Nerissa T., et al.
Publicado: (2022) -
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial
por: Kristensen, Lars Erik, et al.
Publicado: (2022) -
Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
por: Bross, Madeline, et al.
Publicado: (2020)